Related Experiment Videos
Platelet heterogeneity and 111Indium labelling: possible interpretive artefacts in survival studies
British Journal of Haematology
|November 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models.
Journal of controlled release : official journal of the Controlled Release Society·2020
The efficacy, safety and acceptability of emergency embedded Psychiatry Assessment and Planning Units: An evaluation of Psychiatry Assessment and Planning Units in close proximity to their associated emergency departments.
The Australian and New Zealand journal of psychiatry·2020
Platelet Microtubule Subunit Proteins.
Thrombosis and haemostasis·2019
Functional assessment of inherited myeloid neoplasm-associated SAMD9L germline variants via Monoallelic CRISPR modelling.
British journal of haematology·2026
Sickle cell disease and commercial aviation. A retrospective analysis of in-flight and pre-flight medical events.
British journal of haematology·2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
British journal of haematology·2026
Autoimmune neutropenia in children: Test cells versus beads and a role for pro-LL-37 and absolute neutrophil count.
British journal of haematology·2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.
British journal of haematology·2026
Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.
The Iowa orthopaedic journal·2026
Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.
Pakistan journal of medical sciences·2026
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.
Research and practice in thrombosis and haemostasis·2026
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.
Research and practice in thrombosis and haemostasis·2026